The human microbiome is the community of more than 30 trillion microbes, organisms that include bacteria, viruses, archaea and fungi, which reside on and inside the human body. The Company’s vision is to use “omics” based technology to design therapeutics based on consortia of human microbiome.
We believe we have the potential to use the unexplored biology of microbiome and metabolism to develop novel therapies that could transform the treatment of many chronic diseases.
Dr. Deepak Saxena, MS. PhD.
Co-founder and Director
Currently, Deepak Saxena is a Professor and Director of Innovation and Entrepreneurship in the Department of Molecular Pathobiology at NYU College of Dentistry. His laboratory is leading some of the innovative microbiome research programs. Dr. Saxena lab has been funded by more than 15 NIH, DOD, AACR and Lustgarten Foundation grants. He has published exciting work in high impact journals including Nature, Nature Biotechnology, Nature communication, J of Bacteriology, JDR, J of Clinical Microbiology, J of Experimental Medicine, International Journal of Oral Science, and Lab Chip. His work has also appeared in various media outlets including New York Times, Scientific American, Financial Times, NY1 News, Daily News, Men’s Health, NPR, CNN, AADR, Canadian Dental Association, CDA Essential Magazine, and Nova Scotia Dental Association. Dr. Saxena has received various national and international awards. He is an active committee member of various scientific organizations and also serves on various NIH review panel. To translate his research from bench to bedside in 2017, Dr Saxena with Dr Li co-founded Periomicscare LLC, a research spin-off company that aims to create therapeutic microbial ecosystems as biologic drugs for cancer and oral health, on a commercial scale.
Dr. Xin Li PhD.
Co-founder and Director (Research)
Currently, Dr. Xin Li is a tenured Professor at New York University College of Dentistry. Dr. Li’s research has been focused on the interplay among metabolism, microbiome and inflammation in physiological and pathological conditions. Using a combination of metagenomics, metabolomics and molecular approaches, her group recently revealed that succinate signaling plays a central role in inflammation associated with periodontitis, neurodegeneration, and aging. She has published well-cited research articles on regulatory mechanisms of bone remodeling, cancer growth and metastasis, and endocrinology. She has received multiple funding from the National Institutes of Health to explore the biological mechanisms that contribute to the connection of poor oral health and overall health.
Paramjit S. Arora, Ph.D.
Dr. Paramjit Arora is Professor of Chemistry at New York University, Department of Chemistry. He obtained his Ph.D. in Chemistry from the University of California at Irvine and continued with his postdoc at the California Institute of Technology. His research interests include Bioorganic Chemistry and Chemical Biology.
Angela R Kamer, DMD, MS, Ph.D.
Dr. Angela Kamer is Associate Professor in the Department of Periodontology and Implant Dentistry at New York University College of Dentistry. Dr. Kamer obtained her DMD at the Institute of Medicine and Pharmacy, Romania and her Ph.D. at the State University of New York at Buffalo.
Address: 201 E 28th St Ste 11-a. New York, NY, 10016 Tel: 212-375-9698